Septerna, Inc. (SEPN) stock
SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30195% above fair value
$42.60+0.74 (+1.77%)
Close on Nov 13, 2026Market cap $1.99BP/E –Yield –
Septerna EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Septerna
Septerna has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?